Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Hexim Pharmaceuticals Inc.
DescriptionCream in a hydrolipidic base
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDermatitis
Indication DetailsManage and relieve symptoms of radiation-induced dermatitis
Regulatory Designation
PartnerMenarini Group;
Quintiles IMS Holdings Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today